Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Molecular Innovations is a leading primary manufacturer of research reagents, specializing in the fields of coagulation and fibrinolysis. Established in 1990, the company produces a wide array of high-purity proteins, antibodies, and ELISA kits used by pharmaceutical companies and academic institutions worldwide. Their core expertise involves the production of functional proteins and specific assays for targets such as PAI-1, tPA, and various clotting factors. Based in Novi, Michigan, the company maintains a focus on quality and technical precision to support drug discovery and basic life science research. As a primary manufacturer, they provide direct technical support and custom services for their specialized product line.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Molecular Innovations.